Caroline Sabin

Active 1992–2025

216
Papers
30,814
Citations
104
h-index
207
i10-index

Citations

Citations per year for Caroline Sabin1986: 1 citations1993: 3 citations1994: 5 citations1995: 1 citations1996: 8 citations1997: 17 citations1998: 38 citations1999: 42 citations2000: 89 citations2001: 89 citations2002: 85 citations2003: 105 citations2004: 160 citations2005: 166 citations2006: 194 citations2007: 198 citations2008: 296 citations2009: 231 citations2010: 219 citations2011: 246 citations2012: 197 citations2013: 213 citations2014: 181 citations2015: 180 citations2016: 251 citations2017: 131 citations2018: 131 citations2019: 653 citations2020: 574 citations2021: 525 citations2022: 380 citations2023: 270 citations2024: 549 citations2025: 176 citations2026: 6 citations1987–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,366 citing papers, 22.9% of this breakdownUnited Kingdom: 1,148 citing papers, 11.1% of this breakdownItaly: 542 citing papers, 5.2% of this breakdownFrance: 432 citing papers, 4.2% of this breakdownSpain: 430 citing papers, 4.2% of this breakdownCanada: 393 citing papers, 3.8% of this breakdownGermany: 382 citing papers, 3.7% of this breakdownNetherlands: 339 citing papers, 3.3% of this breakdownAustralia: 337 citing papers, 3.3% of this breakdownSwitzerland: 328 citing papers, 3.2% of this breakdownSouth Africa: 314 citing papers, 3% of this breakdownChina: 297 citing papers, 2.9% of this breakdown
0%22.9%Other 29.2%

Fields

  • Medicine79.1%
  • Immunology and Microbiology12.6%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Neuroscience0.9%
  • Health Professions0.7%
  • Psychology0.6%
  • Other2.7%

Topics

  • HIV/AIDS Research and Interventions11.1%
  • HIV Research and Treatment10.1%
  • HIV-related health complications and treatments10.1%
  • HIV/AIDS drug development and treatment7.8%
  • Hepatitis C virus research2.8%
  • Cytomegalovirus and herpesvirus research2.7%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2023 cited by 480

  2. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

    Authors: , , , , , , , , , , , , , , , , , - The Lancet HIV 2023 cited by 128

  3. Plasma Albumin and Incident Cardiovascular Disease

    Authors: , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2019 cited by 207

  4. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

    Authors: , , , , , , , , , , , , , , , - The Lancet 2014 cited by 926

  5. Targeting C-reactive protein for the treatment of cardiovascular disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2006 cited by 676

  6. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , - AIDS 2014 cited by 595

  7. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

    Authors: , , , , , , , , , , , , , , - The Lancet HIV 2018 cited by 220

  8. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 295

  9. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - HIV Medicine 2022 cited by 85

  10. Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

    Authors: , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2009 cited by 647

  11. Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study

    Authors: , , , , , , - BMJ Open 2020 cited by 111

  12. Late presentation of HIV infection: a consensus definition

    Authors: , , , , , , , , , , , , , , , , , , - HIV Medicine 2010 cited by 493

  13. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Avelin F. Aghokeng, Anders Sönnerborg, Ujjwal Neogi, W. Jeffrey Fessel, Simon Agolory, Chunfu Yang, José Luís Blanco, James Juma, Erasmus Smit, Daniel Schmidt, Christine Watera, Juliet Asio, Wilford Kurungi, Anna Tostevin, Tal El‐Hay, Nathan Clumeck, Dominique Goedhals, Cloete van Vuuren, Philip Armand Bester, Caroline Sabin, Irene Mukui, Maria Mercedes Santoro, Carlo Federico Perno, Gillian Hunt, Lynn Morris, Ricardo Camacho, Túlio de Oliveira, Deenan Pillay, Eugene Schulter, Akio Murakami-Ogasawara, Gustavo Reyes‐Terán, Karla Romero, Santiago Ávila‐Ríos, Sunee Sirivichayakul, Kiat Ruxrungtham, Suwanna Mekprasan, David Dunn, Pontiano Kaleebu, Elliot Raizes, Rami Kantor, Robert W. Shafer, Ravindra K. Gupta - The Lancet Infectious Diseases 2016 cited by 275

  14. Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

    Authors: , , , , , , , , , , , , - HIV Medicine 2015 cited by 164

  15. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ken Mayer, José A. Pérez‐Molina, Doreen Moraa, Denise Naniche, Denis Nash, Teymur Noori, Anton Pozniak, Reena Rajasuriar, Peter Reiss, Nesrine Rizk, Jürgen K. Rockstroh, Diana Romero, Caroline Sabin, David Serwadda, Laura Waters - Nature Communications 2021 cited by 159

  16. Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ole Kirk - PLoS Medicine 2013 cited by 360

  17. Experiences of mpox illness and case management among cis and trans gay, bisexual and other men who have sex with men in England: a qualitative study

    Authors: , , , , , , , , , , , , , - EClinicalMedicine 2024 cited by 35

  18. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2002 cited by 1,528

  19. The Coding Causes of Death in HIV (CoDe) Project

    Authors: , , , , , , , , , , , , , , - Epidemiology 2011 cited by 143

  20. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2014 cited by 123

  21. The global burden of cognitive impairment in people with HIV

    Authors: , , - AIDS 2022 cited by 38

  22. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

    Authors: , , , , , - Hepatology 1998 cited by 442

  23. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study

    Authors: , , , , , , , , , , , , , - European Journal of Preventive Cardiology 2015 cited by 233

  24. Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

    Authors: , , , , , , , , , , , , , , - AIDS 2018 cited by 134